Home » Topics » Conferences

Conferences
RSS

SCH-900776 sensitizes cancer cells to hydroxyurea and gemcitabine

April 21, 2010

LCL-161 well tolerated in ongoing first-in-human study

April 21, 2010

Decline of mGlu5 receptor binding as a marker of early Alzheimer's disease

April 21, 2010

ONO-8539 for overactive bladder well tolerated in healthy adults

April 21, 2010

Quinacrine does not extend survival in sporadic Creutzfeldt-Jakob disease

April 21, 2010

Data on vipadenant warrant further development in moderate- to late-stage PD patients

April 21, 2010

MTD of EMD-534085 established in phase I trial in advanced solid tumors and lymphoma

April 20, 2010

Phase Ib safety/efficacy data disclosed on SD-101 in treatment-naive hepatitis C

April 20, 2010

Fab-001 potently active against multiple staphylococcal strains in preclinical study

April 20, 2010

Phase II/III data on tafamidis meglumine in TTR-type familial amyloid polyneuropathy

April 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...